API 0.74% $1.35 australian pharmaceutical industries limited

Ann: API Market Update - 1H15 forecast, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,979 Posts.
    lightbulb Created with Sketch. 4
    Based on this latest update could estimate full year NPAT of around $42 million. Based on market cap of around $650 million after today's 7% jump gives a PE of around 15. Not exceptionally high for a company achieving 30% NPAT growth over previous year. Dividends should also increase. This is in a great sector (health, beauty, pharmaceuticals), I would expect there is room for this stock to go quite a bit higher yet.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.